ESOP27 May 2026, 09:30 pm
Rossari Biotech Grants 830050 Options Under ESOP 2019
AI Summary
Rossari Biotech Ltd. announced the grant of 830050 options under the Rossari Employee Stock Option Plan- 2019. This decision was made during a Board of Directors meeting held on May 27, 2026, following the ratification of the ESOP 2019 by the company's members on April 17, 2021, and based on the recommendation of the Nomination and Remuneration Committee. The board also approved the re-appointment of Ms. Esha Padmanabhan Achan as a Non-Executive Independent Director for a second term, subject to member approval.
Key Highlights
- Rossari Biotech granted 830050 stock options under its ESOP 2019.
- The grant follows member ratification of the ESOP on April 17, 2021.
- Esha Padmanabhan Achan re-appointed as Non-Executive Independent Director.
- Re-appointment is for a second term of 3 years, subject to member approval.
- Board meeting was held on May 27, 2026, where these decisions were approved.
Price Impact
More from ROSSARI